Statistical methods in nephrology & urology trials
The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.
ANCOVA
Non-inferiority trial design
Hazard ratio
Mixed-effects model
Multiple imputation / missing data
Cochran-Mantel-Haenszel test
Odds ratio
Cox proportional-hazards model
All nephrology & urology trials
489 results
- Randomized Study Of Novel Enuresis Alarm vs Standard Bedwetting Alarm: Complete Statistical AnalysisIndependent statistical analysis of Randomized Study Of Novel Enuresis Alarm vs Standard Bedwetting Alarm: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05214131).
- Randomized Trial for Botox Urinary Incontinence: Complete Statistical AnalysisIndependent statistical analysis of Randomized Trial for Botox Urinary Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00178191).
- Rapid Diagnostic Assay for Gonorrhea and Chlamydia: Complete Statistical AnalysisIndependent statistical analysis of Rapid Diagnostic Assay for Gonorrhea and Chlamydia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05564299).
- Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study: Complete Statistical AnalysisIndependent statistical analysis of Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- REAL-ICUIndependent statistical analysis of Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- RECORD-4Independent statistical analysis of Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01491672).
- Rectal Spacer for Prostate Cancer Radiation Image Guidance: Complete Statistical AnalysisIndependent statistical analysis of Rectal Spacer for Prostate Cancer Radiation Image Guidance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05650021).
- RELAX-AHF-EUComplete statistical analysis of RELAX-AHF-EU, a randomized phase 3 trial evaluating serelaxin plus standard of care versus standard of care in patients with acute heart failure, including time-to-event, categorical, continuous, and longitudinal…
- RELAX-AHF-EUIndependent statistical analysis of Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension: Complete Statistical AnalysisIndependent statistical analysis of RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography: Complete Statistical AnalysisIndependent statistical analysis of Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Renal Osteodystrophy: An Individual Management Approach: Complete Statistical AnalysisIndependent statistical analysis of Renal Osteodystrophy: An Individual Management Approach: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02440581).
- Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors: Complete Statistical AnalysisIndependent statistical analysis of Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RESCUEIndependent statistical analysis of Renal Safety Evaluation After Dotarem®-Enhanced MRI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00650845).
- RestoreIndependent statistical analysis of RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02090114).
- REVELUTIONIndependent statistical analysis of RElugolix VErsus LeUprolide Cardiac Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05320406).
- SALTIndependent statistical analysis of Isotonic Solution Administration Logistical Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02345486).
- SALT-EDIndependent statistical analysis and educational interpretation of SALT-ED, a randomized parallel-group trial comparing 0.9% saline with physiologically-balanced isotonic crystalloid in the emergency department.
- SCD PED-02Independent statistical analysis of A Multi-Center Study of a SCD for Immunomodulatory Dysregulation in Pediatric AKI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SCORPIOComplete statistical analysis of the SCORPIO phase 3 trial of mirabegron in patients with symptoms of overactive bladder, including endpoint definitions, ANCOVA methodology, efficacy results, multiplicity, missing-data handling, and safety.
- sipITIndependent statistical analysis of Feasibility of Using sipIT Tools to Increase Compliance With Fluid Consumption Guidelines in Urolithiasis-Prone Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SISTErIndependent statistical analysis of Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00064662).
- SOFTIndependent statistical analysis of Bladder Drainage During Labor: A Randomized Controlled Study of Obstetric Foley Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SOM230Independent statistical analysis of Pasireotide LAR in Severe Polycystic Liver Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01670110).
- SONARIndependent statistical analysis of the phase 3 SONAR trial of atrasentan versus placebo in diabetic nephropathy, including the composite renal endpoint, hazard ratios, confidence intervals, p-values, trial design, and statistical methodology.
- SPARCIndependent statistical analysis of Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SPIRITIndependent statistical analysis of A Representational Intervention to Promote Preparation for End-of-life Decision Making: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01259011).
- STAGED-PKD-EXTIndependent statistical analysis of Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Venglustat: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TAPIndependent statistical analysis of Postoperative Pain Control for Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00913068).
- TARGETIndependent statistical analysis of Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TAXYNERGYIndependent statistical analysis of Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC): primary endpoint results, effect estimate with…
- TEMPO3:4Complete statistical analysis of the TEMPO3:4 phase 3 trial of tolvaptan versus placebo in autosomal dominant polycystic kidney disease, including trial design, endpoints, mixed-effects modeling, recurrent-event analysis, ANCOVA, and reported results.
- TIVO-1Independent statistical analysis of A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TRANQUILITYIndependent statistical analysis of A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TRANSFORMIndependent statistical analysis of Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TRITON3Independent statistical analysis of A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency: primary endpoint results, effect estimate with confidence…
- UCDCC#217Independent statistical analysis of Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- VA NEPHRON-DComplete statistical analysis of VA NEPHRON-D, a randomized phase 3 trial evaluating combination ARB and ACEI therapy versus ARB monotherapy in patients with diabetic nephropathy, including time-to-event endpoints, hazard ratios, confidence intervals,…
- VALUEIndependent statistical analysis of the VALUE phase 3 trial comparing valsartan and amlodipine in essential hypertension, including trial design, the registered composite cardiac endpoint, planned statistical analysis, and interpretation.